NABP DMEPOS Pharmacy Accreditation Consulting
CMS-Required Accreditation for Pharmacies Billing Medicare Part B for Durable Medical Equipment
What Is NABP DMEPOS Pharmacy Accreditation?
NABP DMEPOS Pharmacy Accreditation is a CMS-approved accreditation credential for pharmacies that supply durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) to Medicare beneficiaries and wish to bill those items under Medicare Part B. The Centers for Medicare & Medicaid Services (CMS) requires that all DMEPOS suppliers — including pharmacies — hold accreditation from a CMS-approved accrediting organization as a condition of Medicare Part B billing privileges. NABP is one of the CMS-approved organizations offering this accreditation specifically for pharmacies.
The program verifies that a pharmacy meets the CMS DMEPOS Quality Standards — a comprehensive set of operational, safety, and service requirements — and that it operates in compliance with all applicable Medicare supplier standards. Without this accreditation, a pharmacy cannot bill Medicare Part B for any DMEPOS items, regardless of its state licensure status or overall compliance posture.
Important 2026 update: CMS published a final rule changing DMEPOS Pharmacy Accreditation to a 1-year term starting January 1, 2026, replacing the previous 3-year cycle. Pharmacies that held 3-year accreditations are transitioning to annual renewal. IHS advises current and prospective accredited pharmacies on the implications of this change.
Who Needs DMEPOS Pharmacy Accreditation?
Any pharmacy that bills Medicare Part B for DMEPOS items requires accreditation. Common pharmacy types seeking DMEPOS Pharmacy Accreditation include:
- Independent retail pharmacies that dispense diabetic supplies, blood pressure monitors, nebulizers, walkers, canes, or other covered DMEPOS items and bill Medicare Part B
- Chain pharmacies and their individual locations where DMEPOS billing occurs
- Specialty pharmacies that supply infusion equipment, respiratory therapy supplies, or other DMEPOS categories
- Long-term care pharmacies that provide DMEPOS to residents of skilled nursing or assisted living facilities where the pharmacy holds the Medicare supplier number
- New pharmacy locations of any type that plan to bill Medicare Part B for DMEPOS from day one of operations
Pharmacies that dispense DMEPOS items but bill only Medicaid, commercial insurance, or cash-pay patients are not required to hold DMEPOS Pharmacy Accreditation. However, some state Medicaid programs and commercial payers have adopted CMS's accreditation requirements or have their own analogous requirements. IHS advises clients on the full payer landscape relevant to their operations.
CMS DMEPOS Quality Standards
NABP's DMEPOS Pharmacy Accreditation standards are inclusive of and aligned with the CMS DMEPOS Quality Standards that all CMS-approved accrediting organizations must apply. These standards cover seven core areas:
1. Business Operations
The pharmacy must have clear business policies covering hours of operation, after-hours emergency contact, delivery and setup procedures, complaint handling, and disclosure of business relationships. Policies must be documented, current, and implemented in practice.
2. Financial Management
The pharmacy must maintain adequate financial records, liability insurance, and surety bond coverage. Billing practices must comply with Medicare supplier standards, including accurate coding, documentation of medical necessity, and compliance with competitive bidding area (CBA) requirements where applicable.
3. Products and Services
The pharmacy must only supply DMEPOS items that are covered under Medicare and for which appropriate documentation of medical necessity exists. Items must meet applicable FDA clearance or approval requirements. For rental items, maintenance and repair programs must be documented.
4. Human Resources
Staff who assist patients in selecting, fitting, or using DMEPOS items must be appropriately trained. Certain product categories require credentialed personnel — for example, custom orthotics and prosthetics require licensed practitioners in many states. Personnel files must document qualifications and ongoing training.
5. Physical Environment
Facilities where DMEPOS is stored, dispensed, or delivered must meet safety and sanitation standards. Products must be stored under appropriate conditions and segregated from non-DMEPOS pharmacy inventory where required. Delivery vehicles and equipment used in DMEPOS service delivery must be maintained appropriately.
6. Patient/Beneficiary Rights
Pharmacies must provide Medicare beneficiaries with written notice of their rights, including the right to file complaints, the right to information about Medicare coverage, and the right to privacy. The Advanced Beneficiary Notice (ABN) process must be documented and followed for items where coverage is uncertain.
7. Product-Specific Standards
CMS publishes product-specific quality standards for categories including oxygen and respiratory equipment, power wheelchairs, complex rehabilitative equipment, orthotics and prosthetics, and diabetic supplies. Pharmacies dispensing these specialized categories must meet the product-specific standards in addition to the general quality standards.
NABP DMEPOS Pharmacy Accreditation Eligibility
To be eligible for NABP DMEPOS Pharmacy Accreditation, a pharmacy must:
- Be a licensed pharmacy operating in the United States with current, active licenses in all jurisdictions where it conducts business
- Have been operational for at least 30 days with at least 10 billed prescriptions
- Have a licensed pharmacist in full and actual charge of pharmacy operations and compliance
- Not be located in a personal residence
- Hold or be seeking a Medicare supplier number (NSC/PTAN) from the National Supplier Clearinghouse
- Be in compliance with all applicable federal and state laws
The pharmacy must comply with CMS's 30 Medicare DMEPOS Supplier Standards in addition to NABP's pharmacy-specific criteria. Failure to comply with any of the 30 supplier standards is grounds for loss of Medicare billing privileges independent of accreditation status.
The 2026 Shift to Annual Accreditation
A significant regulatory change took effect January 1, 2026: CMS's final rule changed DMEPOS Pharmacy Accreditation from a 3-year cycle to a 1-year term. This means pharmacies that previously renewed every three years now renew annually. The implications are significant:
- Annual documentation submission and compliance review requirements
- More frequent NABP contact and review cycles
- Higher ongoing compliance maintenance burden for multi-location pharmacies
- Annual accreditation fees rather than triennial fees amortized over three years
IHS helps clients build the internal compliance systems needed to make annual renewal efficient — moving away from reactive, pre-deadline scrambles toward a continuous compliance posture that reduces the burden of each annual cycle.
How IHS Supports DMEPOS Pharmacy Accreditation
IHS structures DMEPOS Pharmacy Accreditation engagements around your pharmacy's specific product mix, size, and current compliance posture. Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — brings the regulatory breadth needed for engagements that span both pharmacy and DMEPOS compliance frameworks.
Gap Assessment Against CMS and NABP Standards
IHS conducts a comprehensive gap assessment mapping your current operations against both the CMS DMEPOS Quality Standards and NABP's pharmacy-specific criteria. For pharmacies with existing Medicare billing activity, the assessment also evaluates your current billing practices and documentation for medical necessity compliance.
Documentation Development
IHS develops or revises the policies, procedures, patient rights notices, ABN protocols, personnel training programs, and product-specific documentation required for accreditation. All documentation is tailored to your specific product categories and operational model.
Annual Renewal Program Design
Given the 2026 shift to annual accreditation, IHS designs internal compliance calendars and documentation management systems that make each annual renewal cycle manageable. This includes setting up monitoring triggers for license expiration, insurance renewal, and required compliance reviews.
Pre-Accreditation Review
Before submitting your NABP application, IHS conducts a complete pre-accreditation review to identify and correct any remaining gaps. We prepare the application package and support submission through to accreditation grant.
Does Your Pharmacy Bill Medicare for DMEPOS?
If your pharmacy bills Medicare Part B for any DMEPOS items — or plans to — NABP DMEPOS Pharmacy Accreditation is a legal requirement. IHS provides the structured consulting expertise to achieve and maintain accreditation efficiently, including under the new annual renewal framework effective in 2026.
Schedule a Free Discovery Session